4//SEC Filing
Shani Eli 4
Accession 0001209191-22-017061
CIK 0000818686other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 4:13 PM ET
Size
13.9 KB
Accession
0001209191-22-017061
Insider Transaction Report
Form 4
Shani Eli
EVP,Global Marketing&Portfolio
Transactions
- Award
Restricted Share Units
2022-03-04+80,428→ 80,428 total→ Ordinary Shares (80,428 underlying) - Exercise/Conversion
Ordinary Shares
2022-03-04+3,173→ 12,264 total - Exercise/Conversion
Restricted Share Units
2022-03-04−3,173→ 3,173 total→ Ordinary Shares (3,173 underlying) - Exercise/Conversion
Ordinary Shares
2022-03-05+5,896→ 18,160 total - Exercise/Conversion
Restricted Share Units
2022-03-05−5,896→ 17,690 total→ Ordinary Shares (5,896 underlying)
Footnotes (5)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]Restricted share units were granted on March 4, 2019, with 3,173 vesting on each of March 4 2022 and March 4, 2023.
- [F4]Restricted share units were granted on March 4, 2022, with 20,107 vesting on each of March 4, 2023, March 4, 2024, March 4, 2025 and March 4, 2026.
- [F5]Restricted share units were granted on March 5, 2021, with 5,896 having vested on March 5, 2022, 5,896 vesting on each of March 5, 2023 and March 5, 2024, and 5,898 vesting on March 5, 2025.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001876642
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 4:13 PM ET
- Size
- 13.9 KB